Breakdown | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 2.60B | 2.90B | 3.21B | 3.07B | 2.11B |
Gross Profit | 34.18M | 316.20M | 793.27M | 813.18M | 34.21M |
EBITDA | -36.64M | 306.48M | 813.12M | 695.48M | 147.50M |
Net Income | -505.39M | -152.34M | 201.56M | 379.24M | -241.78M |
Balance Sheet | |||||
Total Assets | 5.41B | 6.27B | 5.85B | 4.04B | 2.85B |
Cash, Cash Equivalents and Short-Term Investments | 8.10M | 62.93M | 224.06M | 413.26M | 14.54M |
Total Debt | 3.40B | 3.69B | 3.14B | 2.56B | 2.18B |
Total Liabilities | 5.05B | 5.35B | 4.79B | 3.21B | 2.83B |
Stockholders Equity | 403.22M | 908.10M | 1.06B | 822.07M | 16.98M |
Cash Flow | |||||
Free Cash Flow | -111.57M | 5.69M | -58.83M | -228.16M | -52.82M |
Operating Cash Flow | -103.33M | 224.47M | 715.30M | 435.30M | 6.58M |
Investing Cash Flow | 280.47M | -718.51M | -1.16B | -650.26M | -57.80M |
Financing Cash Flow | -232.57M | 332.57M | 272.77M | 593.86M | 55.62M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
73 Outperform | HK$3.22B | 6.67 | 8.22% | 7.69% | -2.46% | 20.39% | |
69 Neutral | HK$1.06B | 11.51 | 4.75% | 2.12% | -13.75% | -56.14% | |
54 Neutral | HK$1.03B | 14.10 | 2.75% | 3.42% | -11.89% | -69.45% | |
49 Neutral | HK$2.03B | 3.41 | 11.49% | ― | 47.32% | 492.76% | |
44 Neutral | C$992.05M | -6.72 | -13.73% | 2.53% | 17.45% | -32.50% | |
36 Underperform | HK$150.70M | ― | -76.72% | ― | -12.18% | -222.34% | |
€16.12M | ― | -10.94% | ― | ― | ― |
Ko Yo Chemical (Group) Limited has announced updates regarding its financial strategies and operational adjustments to address going concern issues. The company has successfully renewed or restructured significant bank loans and negotiated with bondholders to defer repayments, while also engaging with the Sichuan government for support in the natural gas sector. Additionally, the company is optimizing its sales model and advancing production projects, which are expected to enhance its market positioning and operational efficiency.
Ko Yo Chemical (Group) Limited announced the results of its Annual General Meeting (AGM) held on 30 May 2025, where all proposed resolutions were passed unanimously by shareholders. The resolutions included the adoption of financial statements, re-election of directors, authorization of directors’ remuneration, re-appointment of auditors, and granting of mandates for share issuance and repurchase. This successful AGM reflects strong shareholder support and positions the company for continued operational stability and strategic growth.
Ko Yo Chemical (Group) Limited has announced the appointment of Mr. Fan Chao as an executive director, effective from May 1, 2025. Mr. Fan, currently serving as deputy vice president, brings extensive experience in chemical and biological engineering, having held various positions in Siemens and other companies. His appointment is expected to strengthen the company’s leadership and potentially enhance its market position.
Ko Yo Chemical (Group) Limited announced the composition of its board of directors and their roles within the company. The board includes both executive and independent non-executive directors, with specific members assigned to the audit, remuneration, and nomination committees. This announcement provides clarity on the governance structure of the company, potentially impacting its operational transparency and stakeholder confidence.
Ko Yo Chemical (Group) Limited has announced its annual general meeting scheduled for May 30, 2025, in Hong Kong. The meeting will address several key resolutions, including the adoption of financial statements, re-election of directors, and re-appointment of auditors. Additionally, the company seeks approval to allot and issue shares, which could impact its capital structure and shareholder value.